We also used specific siRNAs to silence YTHDF1 in breast cancer cells and observed that YTHDF1 knockdown would significantly inhibit cell proliferation through inducing apoptosis, indicating that YTHDF1 could be exploited as a potential therapeutic target for breast cancer treatment. This evidence concerns the gene YTHDF1 and breast cancer.